Common Contracts
2 similar Commercial Packaging Agreement contracts by Neurocrine Biosciences Inc
EX-99.3 4 d376977dex993.htm EX-99.3 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 240.24b-2. COMMERCIAL PACKAGING AGREEMENTCommercial Packaging Agreement • May 5th, 2020 • Delaware
This Commercial Packaging Agreement (“Agreement”) is made as of this 12th day of December, 2016 (“Effective Date”), by and among Neurocrine Biosciences Inc., a corporation organized under the laws of Delaware, with offices at 12780 El Camino Real, San Diego, California, 92130, USA (“Client”) and AndersonBrecon Inc., an Illinois corporation, doing business as PCI of Illinois , with a place of business at 4545 Assembly Drive, Rockford, IL 61109 ( “PCI”).
COMMERCIAL PACKAGING AGREEMENTCommercial Packaging Agreement • April 25th, 2017 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • Delaware
This Commercial Packaging Agreement (“Agreement”) is made as of this 12th day of December, 2016 (“Effective Date”), by and among Neurocrine Biosciences Inc., a corporation organized under the laws of Delaware, with offices at 12780 El Camino Real, San Diego, California, 92130, USA (“Client”) and AndersonBrecon Inc., an Illinois corporation, doing business as PCI of Illinois , with a place of business at 4545 Assembly Drive, Rockford, IL 61109 ( “PCI”).
